{"disease":{"id":"ivm","name":"ivm"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03405701","title":"IVM Versus IVF in High Antral Follicle Count Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":546,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT04296357","title":"Health of IVF Versus IVM Children (FM-BABIES)","phase":"","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT06369415","title":"Health of Babies Born From IVF Versus IVM at 5 Years Old","phase":"","overall_status":"COMPLETED","enrollment_count":214,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT04488211","title":"IVM Survey Among Reproductive Medicine Specialists","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Universitair Ziekenhuis Brussel","has_results":false},{"nct_id":"NCT02211131","title":"Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT02366195","title":"Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04774432","title":"Effect of GM-CSF on CAPA-IVM System Success Rates in PCOS","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT04048486","title":"Children Born From IVM-CAPA vs IVF or Natural Conception","phase":"","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT06633120","title":"In Vitro Maturation of Human Eggs","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Colorado Center for Reproductive Medicine","has_results":false},{"nct_id":"NCT05793931","title":"A Pilot Study to Determine the Feasibility, Acceptance, and Effectiveness of In-vitro Maturation in Patients Without IVF Coverage","phase":"","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT04297553","title":"Fresh Versus Freeze-only After CAPA IVM on PCOS Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT03915054","title":"Amphiregulin Versus Non-Amphiregulin Supplementation to Maturation Culturing Medium in IVM.","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT06087354","title":"Low vs. Air Oxygen Concentration CAPA-IVM Culture of Cumulus-oocyte Complexes","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT04562883","title":"Single vs. Group CAPA-IVM Culture of Cumulus-oocyte Complexes","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT07197255","title":"Transcriptomic Profiling of Cumulus Cells From CAPA-IVM","phase":"","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT03972046","title":"Neoadjuvant Use of Talimogene Laherparepvec and BRAF/MEK Inhibitor for Advanced Nodal BRAF Mutant Melanoma","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"TriHealth Inc.","has_results":false},{"nct_id":"NCT02297529","title":"Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT02147951","title":"Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Amgen","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}